Scientists analyze blood to test for toxic airplane air exposure

Inside a freezer in a research laboratory at the University of Washington are blood and blood plasma samples from 92 people who suffer from mysterious illnesses, including tremors, memory loss and severe migraine headaches. They are mostly pilots and flight attendants who suspect they’ve been poisoned in their workplace — on board the aircraft they fly. Clement Furlong, University of Washington professor of medicine and genome sciences, leads a team of scientists who have been collecting the samples for 2 ½ years.

Share

Experts: Many young Muslim terrorists spurred by humiliation

At first, no one seemed to notice the young man who walked into the hotel lobby at around 7:45 that Friday morning. He wore a baseball cap, a backpack and dragged a wheeled suitcase behind him. He casually checked his watch as he calmly walked toward a hotel restaurant filled with Western business executives

Share

Denosumab: Experimental Drug Helps Ward Off Osteoporosis

An experimental drug has successfully reduced hip and spine fractures in the two largest patient populations at risk for osteoporosis — postmenopausal women and men being treated for prostate cancer — according to two major studies published online on Aug. 11 by the New England Journal of Medicine

Share

Study: Tamiflu may do children more harm than good

Treating flu-stricken children with anti-viral medication including Tamiflu and Relenza could do more harm than good, a new report has warned. Researchers from the University of Oxford found that while the anti-virals reduced the duration of illness by up to one day and a half, they had “little or no effect” on the likelihood of the children developing complications. The researchers conceded that they didn’t know the extent to which their report applied to the current swine flu pandemic, but said, “based on current evidence, the effects of anti-virals on reducing the course of illness or preventing complications might be limited.” In compiling their report, published in the British Medical Journal, the Oxford University researchers searched the world for trials of Tamiflu and Relenza on children under 12.

Share